Prevention of Anemia in Patients with Solid Tumors Receiving Platinum-Based Chemotherapy by Recombinant Human Erythropoietin (rHuEpo): A Prospective, Open Label, Randomized Trial by the Hellenic Cooperative Oncology Group

Publisher： Karger

E-ISSN： 1423-0232|64|2|102-110

ISSN： 0030-2414

Source： Oncology, Vol.64, Iss.2, 2003-02, pp. : 102-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Recombinant Human Erythropoietin (rHuEPO) on Tumor Control in Patients with Cancer-Induced Anemia

By  

Oncology Research and Treatment, Vol. 28, Iss. 4, 2005-10 ,pp. : 216-221

Karger

Access to resources Recommend Favorite

Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience

By  

Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 104-107

Karger

Access to resources Recommend Favorite

Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1081-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite